Pfizer Withdraws EUA Application for COVID Shot in India After Regulator Asks for Independent Safety Study
Pfizer, Inc. has withdrawn its emergency use authorization (EUA) application for its experimental BNT162b2 (also known as “Comirnaty”) messenger RNA (mRNA) COVID-19 biologic (developed in collaboration with Germany’s BioNTech) in India.1 Pfizer was the first pharmaceutical company to apply for an EUA to distribute a COVID biologic in India in 2021. However, India’s regulatory agency […]
Novavax’s Protein COVID-19 Vaccine Now Available in Europe
Novavax’s experimental NVX-CoV2373 (also known as “Nuvaxovid” and “Covovax”) COVID-19 vaccine has been authorized for distribution in the European Union (E.U.), making it the fifth COVID vaccine available for use in the E.U. Approved for people over 18 years old, Nuvaxoid is the first protein subunit COVID vaccine to be approved for use.1 2 The […]
Renewable Travel Pass May Signal Annual Booster Shots for European Union
As part of an effort to reopen their borders and encourage travelers from outside of Europe, the 27 member states of the European Union (E.U.) began issuing an “E.U. Digital COVID Certificate” (EUDCC) on July 1, 2021 to people who have receive COVID vaccinations to allow freedom of movement within the region. The travel scheme, […]
Tennessee Man Dies Three Days After Getting Second Pfizer COVID Shot
A 36-year-old man in Madison County, Tennessee died unexpectedly on Sept. 25, 2021, three days after receiving the second dose of Pfizer/BioNTech’s experimental messenger RNA (mRNA) BNT162b2 biologic for COVID-19. Timothy Adam Hornsby was vaccinated on Sept. 22 and started feeling ill the next morning. His health took a turn for the worse two days […]
Stanford Epidemiologist Says COVID Vaccination is Primarily a Matter of Personal Health, Not Public Health
Opinion | As one-size-fits-all COVID vaccine mandates sweep government, academia, and corporate America, new data are emerging that undermine the public health justifications for these policies. Studies from multiple countries now indicate that vaccination alone is less effective than the acquired immunity many already possess and unable to prevent transmission in the medium-to-long term. Since the pandemic began, more […]
Guillain-Barré Syndrome Warning Added to AstraZeneca’s Vaxzevria COVID Vaccine in Europe
The European Medicines Agency (EMA) last week added an autoimmune condition known as Guillain-Barré syndrome (GBS) as a possible side effect to the product information on AstraZeneca/Oxford University’s Vaxzevria (or “AZD1222”) experimental adenovirus vectored vaccine. GBS is a neurological disorder that causes pain, numbness, muscle weakness and sometimes paralysis.1 2 3 4 A total of […]
